Physician profile
Raza Abbas
NPI 1245549112
$3,760.77
in general payments reported to CMS, 2019-2025
30 companies · $1,087 in 2025
The $1,087 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $189 · 2020: $153 · 2021: $471 · 2022: $467 · 2023: $708 · 2024: $687 · 2025: $1,087.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,061 · Travel and Lodging: $420.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,060.86 |
| Travel and Lodging | $420.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $816.26 | 2022-2025 | Impella |
| Edwards Lifesciences Corporation | $416.76 | 2023-2024 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve, Pascal |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $376.09 | 2019-2024 | Lifevest |
| Boston Scientific Corporation | $370.79 | 2021-2025 | Watchman Flx, General - Balloon Catheters, Avvigo Guidance System |
| Abbott Laboratories | $290.20 | 2019-2024 | Coroflow |
| Medtronic, INC. | $242.98 | 2021-2024 | Onyx Frontier |
| Pfizer INC. | $192.12 | 2022-2025 | |
| Baxter Healthcare | $177.20 | 2023-2024 | Hillrom - Cardiac Ambulatory Monitor, Hillrom - Carnation Ambulatory Monitor |
| Angiodynamics, INC. | $150.56 | 2021-2023 | Alphavac |
| Amgen INC. | $114.33 | 2021-2025 | Repatha |
| E.R. Squibb & Sons, L.L.C. | $97.90 | 2020-2025 | Camzyos |
| Novo Nordisk INC | $58.76 | 2021-2025 | Wegovy |
| Teleflex LLC | $50.34 | 2025 | Turnpike, Trapliner |
| Impulse Dynamics (USA) INC. | $48.03 | 2023-2025 | Optimizer, Optimizer |
| Daiichi Sankyo INC. | $35.82 | 2022-2023 | Injectafer |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $32.05 | 2023-2024 | |
| Merck Sharp & Dohme LLC | $30.76 | 2022-2023 | Verquvo |
| Atricure, INC. | $29.84 | 2023 | |
| Chiesi USA, INC. | $28.12 | 2020-2021 | |
| Esperion Therapeutics, INC. | $24.84 | 2025 | Nexletol |
| Getinge USA Sales, LLC | $24.44 | 2022 | |
| Heartflow, INC. | $23.50 | 2025 | |
| Kestra Medical Technology Services, INC. | $21.26 | 2024 | Assure Wcd |
| Cardiovascular Systems INC. | $20.87 | 2020 | |
| Cvrx, INC. | $18.95 | 2023 | Barostim Neo System |
| Scpharmaceuticals INC. | $15.68 | 2023 | |
| Medtronic Vascular, INC. | $14.80 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $14.78 | 2021 | |
| Janssen Pharmaceuticals, INC | $12.74 | 2022 | |
| Bardy Diagnostics, INC. | $10.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Raza Abbas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.